Enzybiotics are an experimental antibacterial therapy.
Classification
Mechanism
Endolysins are specialized enzymes derived from bacteriophages,
that infect bacterial cells in order to replicate within them. Because phages have coevolved with their bacterial hosts, the endolysin system is very efficient at degrading bacterial
.
Phages release endolysins from inside bacterial host cells that cleave the
peptidoglycan bonds of the bacterial cell wall.
Once the cell is lysed, the bacteriophage is able to release progeny virions into the environment which in turn infect more bacterial cells.
In addition to degrading bacterial cell walls from within, endolysins are effective when applied externally and can lyse Gram-positive bacteria that lack an outer
cell membrane.
Enzybiotics utilize endolysins to combat
, exploiting their ability to home in on specific bacterial cells, their nontoxicity toward
Eukaryote cells, and a decreased risk of pathogen resistance because they target highly conserved peptidoglycan bonds.
A rapid killing rate of bacteria has also been observed upon administration of endolysins due to the enzymatic mechanism, as have synergistic effects among different endolysins and in combination with antibiotics, improving treatment outcomes of bacterial infections.
Research
In one of the earliest studies of endolysins as antibacterial therapy, oral
streptococcus infections of mice were completely eradicated following bacteriophage endolysin treatment.
Subsequent studies have demonstrated that endolysins of streptococcal phages ƛSA2 and B30, as well as endolysins LysK, CHAPK, and an engineered lysin LysKΔamidase all significantly reduced the activity of several Streptococcus species responsible for bovine mastitis, a widespread and costly concern in the dairy industry.
Endolysins including LYSDERM-S, derived from Staphylococcus phage 812 (
Kayvirus), were effective in destroying drug-resistant strains of
Staphylococcus aureus, a pathogen causing chronic MRSA wound infections.
Bacteriophage endolysins have been successful in preventing
Infant infections of penicillin-resistant
Streptococcus agalactiae, a pathogen that is the leading cause of
sepsis,
meningitis, and
pneumonia in newborns.
Other studies have demonstrated the efficacy of endolysins in combating infection by various
Bacillus,
Enterococcus, and Streptococcus species, as well preventing
biofilm formation of
Escherichia coli and
Listeria monocytogenes.
History
Antibiotic resistance
As of July 2020, the World Health Organization considers antibiotic resistance “one of the biggest threats to global health, food security, and development today”.
The processes by which pathogens become drug-resistant vary, but several types of antibiotic misuse, including self-medication and over-prescription of antibiotics in elderly communities have been implicated in the prevalence of drug-resistant
Streptococcus pneumoniae (PRSP),
Staphylococcus aureus (MRSA), and other Gram-negative bacilli.
Once easily-treatable conditions like urinary tract infections have become increasingly difficult to address as infection-causing bacteria have developed resistance to multiple drugs.
The growing number of antibiotic-resistant pathogens has prompted calls for research into innovative antimicrobial therapies.
See also
